Subsequent Events	3 Months Ended
Mar. 31, 2026
Subsequent Events [Abstract]
Subsequent Events	Subsequent Event On April 6, 2026, the Company closed an underwritten public offering (the “April 2026 Offering”) relating to the issuance and sale by the Company of 12,500,000 shares of its common stock, par value $0.001 per share, and accompanying 2026 Warrants, at a combined public offering price of $1.40 per share of common stock and accompanying 2026 Warrants. The net proceeds to the Company from the April 2026 Offering were $16.0 million, after deducting the underwriting discounts and commissions and offering expenses paid by the Company. In connection with the April 2026 Offering, the Company issued the 2026 Series A Warrants and 2026 Series B Warrants. The Company has evaluated the terms of the 2026 Warrants and determined that, consistent with the analysis applied to the December 2024 Warrants and July 2025 Warrants, the 2026 Warrants are not indexed to the Company's common stock and therefore will be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value recognized in the condensed consolidated statements of operations. The Company will record the initial fair value of the 2026 Warrant liabilities in the second quarter of 2026.

Subsequent Events

3 Months Ended

Mar. 31, 2026

Subsequent Event

On April 6, 2026, the Company closed an underwritten public offering (the “April 2026 Offering”) relating to the issuance and sale by the Company of 12,500,000 shares of its common stock, par value $0.001 per share, and accompanying 2026 Warrants, at a combined public offering price of $1.40 per share of common stock and accompanying 2026 Warrants. The net proceeds to the Company from the April 2026 Offering were $16.0 million, after deducting the underwriting discounts and commissions and offering expenses paid by the Company. In connection with the April 2026 Offering, the Company issued the 2026 Series A Warrants and 2026 Series B Warrants. The Company has evaluated the terms of the 2026 Warrants and determined that, consistent with the analysis applied to the December 2024 Warrants and July 2025 Warrants, the 2026 Warrants are not indexed to the Company's common stock and therefore will be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value recognized in the condensed consolidated statements of operations. The Company will record the initial fair value of the 2026 Warrant liabilities in the second quarter of 2026.